{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-24-000054","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.701408+00:00","generated_at":"2026-05-31T09:30:14.745968+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cardinal Health Q4 revenue +12% to $59.9B, non-GAAP EPS $1.84 (+29%); raises FY25 guidance to $7.55-$7.70","bullets":["Q4 revenue $59.9B (+12% YoY); GAAP EPS $0.96, non-GAAP EPS $1.84 (+29%).","FY2024 revenue $226.8B (+11%), non-GAAP EPS $7.53 (+29%); operating cash flow record $3.8B.","FY2025 non-GAAP EPS guidance raised to $7.55-$7.70 from at least $7.50.","Pharmaceutical & Specialty Solutions segment profit +8% to $482M; GMPD profit $47M vs $7M YoY.","GMPD segment profit improved $40M to $47M driven by net inflationary mitigation initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-24-000054","json":"https://secwatch.observer/filing/0000721371-24-000054.json","markdown":"https://secwatch.observer/filing/0000721371-24-000054.md","text":"https://secwatch.observer/filing/0000721371-24-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137124000054/0000721371-24-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137124000054/cah-20240814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:30:14.745968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}